- Home
- APRE vs BKYI Comparison
APRE vs BKYI Comparison
Compare APRE & BKYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APRE | BKYI |
|---|---|---|
| Founded | 2006 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 6.8M |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | APRE | BKYI |
|---|---|---|
| Price | $0.72 | $0.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.10 | N/A |
| AVG Volume (30 Days) | ★ 216.2K | 179.8K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $6,302,984.00 |
| Revenue This Year | N/A | $7.45 |
| Revenue Next Year | N/A | $23.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 111.81 |
| 52 Week Low | $0.55 | $0.49 |
| 52 Week High | $2.22 | $1.97 |
Technical Indicators
Market Signals| Indicator | APRE | BKYI |
|---|---|---|
| Relative Strength Index (RSI) | 45.75 | 40.36 |
| Support Level | $0.55 | $0.53 |
| Resistance Level | $0.98 | $0.63 |
| Average True Range (ATR) | 0.07 | 0.05 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 48.08 | 26.81 |
Price Performance
Historical ComparisonAbout APRE Aprea Therapeutics Inc.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.